✓ Last verified: February 13, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Greenbrook TMS Agoura Hills is part of the national Greenbrook network offering FDA-cleared treatments for treatment-resistant depression. This location provides Spravato (esketamine nasal spray) and NeuroStar TMS therapy, both covered by most major insurance plans. Greenbrook’s standardized clinical protocols ensure consistent quality across all locations, and their Agoura Hills center serves patients throughout the western San Fernando Valley, Thousand Oaks, and Conejo Valley communities seeking advanced, insurance-covered depression treatment.
| Google Reviews | ⭐ 4.5 (National Network) |
| Location | Agoura Hills, California |
| Address | 30343 Canwood Street, Suite 104, Agoura Hills, CA 91301 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | Spravato (Esketamine Nasal Spray), NeuroStar TMS Therapy |
| Conditions Treated | Treatment-Resistant Depression, MDD with Suicidal Ideation |
| Cost | Covered by most major insurance plans |
| Insurance | Most major insurance accepted for both Spravato and TMS |
| KAP Available | No — Spravato administered under medical supervision (not KAP) |
| Clinical Lead | Greenbrook TMS Clinical Team |
HealingMaps Take: Greenbrook’s biggest advantage is insurance coverage — both Spravato and TMS are covered by most major plans, making these treatments accessible to patients who can’t afford $400–$800 per session out of pocket for IV ketamine. While Greenbrook doesn’t offer IV ketamine or KAP, Spravato is an FDA-approved ketamine-derived option backed by rigorous clinical trials. The Agoura Hills location is convenient for patients in the western LA suburbs and Ventura County border communities. For patients whose insurance covers Spravato, Greenbrook removes the financial barrier that often makes ketamine-based treatment inaccessible.
Market Position: Greenbrook TMS is a Spravato-certified clinic in the Hills metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
Industry pricing reference. Greenbrook TMS’s posted price: Covered by most major insurance plans. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions Greenbrook TMS treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Greenbrook TMS offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Greenbrook TMS treats depression via Spravato (FDA-cleared for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
This clinic provides three FDA-cleared interventional psychiatry options: ketamine therapy, Spravato (esketamine), and TMS therapy. TMS sessions take 19 to 37 minutes (or 3 minutes for the iTBS protocol), with no anesthesia, sedation, or controlled-substance handling. This clinic uses BrainsWay Deep TMS, the only TMS device with standalone FDA clearance for OCD via the H7 coil. Read our complete guide to TMS therapy for FDA-cleared conditions, device differences, insurance coverage by carrier, and what to expect at your first appointment. Browse verified TMS clinics in our directory.
View all REMS-certified Spravato clinics in California and across the United States.
Leave a Reply